معرفی
Dr Johnson Jianzhong Liu is a researcher at the University of New South Wales, affiliated with the School of Medical Sciences and Department of Pharmacology. His work bridges cancer pharmacology, experimental therapeutics, and drug transporter biology.
- BSc, MSc in Veterinary Medicine from Northwest A & F University
- PhD in Pharmacology from South China Agricultural University
- Graduate Certificate in University Learning & Teaching (GCULT), UNSW
Dr Liu’s research focuses on copper transporters and organic cation transporters in chemotherapy-induced neurotoxicity, Wnt signaling in targeted cancer therapy, and genetic polymorphisms affecting platinum drug response and lung cancer risk in Chinese Han populations. His lab employs in vitro and in vivo models to study vascular-disrupting flavonoids and mulberry fruit extracts in cancer treatment.
Recent publications highlight his expertise in platinum-based drug mechanisms (oxaliplatin resistance via MRP2), cancer-related miRNA regulation, and traditional Chinese medicine applications for inflammation and tumor suppression. His work spans pharmacokinetics, drug transport, and pharmacogenomics.
Dr Liu serves on the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists and the American Association for Cancer Research. He mentors PhD, Masters, Honours, and ILP students in projects involving Wnt signaling and drug transporter modulation.
